March 17, 2026

ALS Trial Tests Celecoxib–Ciprofloxacin Combination

Dual-drug therapy showed signals of slower disease progression and reduced complications in patients with ALS.

Conexiant

March 17, 2026

Aneurysmal Hemorrhage Triggers Systemic Effects

Researchers examine physiologic responses following rupture and link them to outcomes.

Conexiant

March 16, 2026

AF Stroke Prevention: Testing Ablation

In the randomized STABLED trial, adding catheter ablation to edoxaban did not reduce recurrent stroke or major cardiovascular outcomes.

Conexiant

March 16, 2026

‘Freezing Of Gait’ Gets New Definition

Framework clarifies clinical and research evaluation of freezing of gait.

Conexiant

March 12, 2026

Medical Oddities: Allergies, Meet Your Match in Matcha

Matcha muting sneezes, snack foods nudging fracture risk, firstborns navigating baby-number-two drama, and more this week.

Conexiant

March 11, 2026

PCPs Unite to Strengthen Negotiating Power

Primary care practices are increasingly joining Independent Physician Associations to strengthen negotiating power with insurers and remain independent.

KFF Health News

March 10, 2026

FDA Approves Therapy for Cerebral Folate Deficiency

Decision addresses a rare neurologic disorder linked to folate transport impairment.

Conexiant

March 05, 2026

Medical Oddities: The Calmest Move in Cardiology?

Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.

Conexiant

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant

March 04, 2026

Cenobamate Shows Stronger Real-World Seizure Control

Large retrospective analysis highlights differences in seizure control, retention, and adverse effects among newer agents

Conexiant